Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

1.

Interaction of HIV-1 gp41 core with NPF motif in Epsin: implication in endocytosis of HIV.

Huang JH, Qi Z, Wu F, Kotula L, Jiang S, Chen YH.

J Biol Chem. 2008 May 30;283(22):14994-5002. doi: 10.1074/jbc.M800525200. Epub 2008 Mar 28.

PMID:
18375383
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Identification of the HIV-1 gp41 core-binding motif--HXXNPF.

Huang JH, Liu ZQ, Liu S, Jiang S, Chen YH.

FEBS Lett. 2006 Sep 4;580(20):4807-14. Epub 2006 Aug 4.

PMID:
16904109
[PubMed - indexed for MEDLINE]
Free Article
3.

Identification of the HIV-1 gp41 core-binding motif in the scaffolding domain of caveolin-1.

Huang JH, Lu L, Lu H, Chen X, Jiang S, Chen YH.

J Biol Chem. 2007 Mar 2;282(9):6143-52. Epub 2006 Dec 31.

PMID:
17197700
[PubMed - indexed for MEDLINE]
Free Article
4.

Identification of a critical motif for the human immunodeficiency virus type 1 (HIV-1) gp41 core structure: implications for designing novel anti-HIV fusion inhibitors.

He Y, Cheng J, Li J, Qi Z, Lu H, Dong M, Jiang S, Dai Q.

J Virol. 2008 Jul;82(13):6349-58. doi: 10.1128/JVI.00319-08. Epub 2008 Apr 16.

PMID:
18417584
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

The mechanism by which molecules containing the HIV gp41 core-binding motif HXXNPF inhibit HIV-1 envelope glycoprotein-mediated syncytium formation.

Huang JH, Yang HW, Liu S, Li J, Jiang S, Chen YH.

Biochem J. 2007 May 1;403(3):565-71.

PMID:
17223796
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Identification of a human protein-derived HIV-1 fusion inhibitor targeting the gp41 fusion core structure.

Chao L, Lu L, Yang H, Zhu Y, Li Y, Wang Q, Yu X, Jiang S, Chen YH.

PLoS One. 2013 May 31;8(5):e66156. doi: 10.1371/journal.pone.0066156. Print 2013.

PMID:
23741527
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Reversible and efficient activation of HIV-1 cell entry by a tyrosine-sulfated peptide dissects endocytic entry and inhibitor mechanisms.

Platt EJ, Gomes MM, Kabat D.

J Virol. 2014 Apr;88(8):4304-18. doi: 10.1128/JVI.03447-13. Epub 2014 Jan 29.

PMID:
24478426
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Conserved salt bridge between the N- and C-terminal heptad repeat regions of the human immunodeficiency virus type 1 gp41 core structure is critical for virus entry and inhibition.

He Y, Liu S, Li J, Lu H, Qi Z, Liu Z, Debnath AK, Jiang S.

J Virol. 2008 Nov;82(22):11129-39. doi: 10.1128/JVI.01060-08. Epub 2008 Sep 3.

PMID:
18768964
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Discovery of critical residues for viral entry and inhibition through structural Insight of HIV-1 fusion inhibitor CP621-652.

Chong H, Yao X, Qiu Z, Qin B, Han R, Waltersperger S, Wang M, Cui S, He Y.

J Biol Chem. 2012 Jun 8;287(24):20281-9. doi: 10.1074/jbc.M112.354126. Epub 2012 Apr 16.

PMID:
22511760
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Trimeric, coiled-coil extension on peptide fusion inhibitor of HIV-1 influences selection of resistance pathways.

Zhuang M, Wang W, De Feo CJ, Vassell R, Weiss CD.

J Biol Chem. 2012 Mar 9;287(11):8297-309. doi: 10.1074/jbc.M111.324483. Epub 2012 Jan 10.

PMID:
22235115
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Identification of a gp41 core-binding molecule with homologous sequence of human TNNI3K-like protein as a novel human immunodeficiency virus type 1 entry inhibitor.

Zhu Y, Lu L, Xu L, Yang H, Jiang S, Chen YH.

J Virol. 2010 Sep;84(18):9359-68. doi: 10.1128/JVI.00644-10. Epub 2010 Jun 30.

PMID:
20592080
[PubMed - indexed for MEDLINE]
Free PMC Article
12.
13.

Conserved residue Lys574 in the cavity of HIV-1 Gp41 coiled-coil domain is critical for six-helix bundle stability and virus entry.

He Y, Liu S, Jing W, Lu H, Cai D, Chin DJ, Debnath AK, Kirchhoff F, Jiang S.

J Biol Chem. 2007 Aug 31;282(35):25631-9. Epub 2007 Jul 6.

PMID:
17616522
[PubMed - indexed for MEDLINE]
Free Article
14.

Interactions of HIV-1 inhibitory peptide T20 with the gp41 N-HR coiled coil.

Champagne K, Shishido A, Root MJ.

J Biol Chem. 2009 Feb 6;284(6):3619-27. doi: 10.1074/jbc.M809269200. Epub 2008 Dec 10.

PMID:
19073602
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

ADS-J1 inhibits HIV-1 infection and membrane fusion by targeting the highly conserved pocket in the gp41 NHR-trimer.

Yu F, Lu L, Liu Q, Yu X, Wang L, He E, Zou P, Du L, Sanders RW, Liu S, Jiang S.

Biochim Biophys Acta. 2014 May;1838(5):1296-305. doi: 10.1016/j.bbamem.2013.12.022. Epub 2014 Jan 3.

PMID:
24388952
[PubMed - indexed for MEDLINE]
18.

HIV-1 variants with a single-point mutation in the gp41 pocket region exhibiting different susceptibility to HIV fusion inhibitors with pocket- or membrane-binding domain.

Lu L, Tong P, Yu X, Pan C, Zou P, Chen YH, Jiang S.

Biochim Biophys Acta. 2012 Dec;1818(12):2950-7. doi: 10.1016/j.bbamem.2012.07.020. Epub 2012 Jul 31.

PMID:
22867851
[PubMed - indexed for MEDLINE]
Free Article
19.

Interactions of the cytoplasmic domains of human and simian retroviral transmembrane proteins with components of the clathrin adaptor complexes modulate intracellular and cell surface expression of envelope glycoproteins.

Berlioz-Torrent C, Shacklett BL, Erdtmann L, Delamarre L, Bouchaert I, Sonigo P, Dokhelar MC, Benarous R.

J Virol. 1999 Feb;73(2):1350-61.

PMID:
9882340
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

A low-molecular-weight entry inhibitor of both CCR5- and CXCR4-tropic strains of human immunodeficiency virus type 1 targets a novel site on gp41.

Murray EJ, Leaman DP, Pawa N, Perkins H, Pickford C, Perros M, Zwick MB, Butler SL.

J Virol. 2010 Jul;84(14):7288-99. doi: 10.1128/JVI.00535-10. Epub 2010 Apr 28.

PMID:
20427524
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk